CLINICAL_TRIALS
trial_result
· 2015-03-18
Clinical Trial Update: Celecoxib in Patients With Newly Diagnosed GBM Who Are Receiving Anticonvulsant Drugs and Undergoing RT [Phase 2]
Summary
A Phase 2 trial of celecoxib in newly diagnosed glioblastoma patients receiving anticonvulsants and radiotherapy was terminated, with results posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: TERMINATED | Results posted: 2015-03-18